LABO M.D.
0691.703.238 · rovalta.com · 28/09/2026
ACTIVE
LABO M.D.
Financial year 2025 · Closed on 31/12/2025
Net result142,3 k €-29,1 %over 1 year
Gross margin260,7 k €-16,8 %over 1 year
Equity199,7 k €-14,8 %over 1 year
Overview
Identity
Source · BCE/KBOLABO M.D. is a Private limited company incorporated in 2018. Its main activity is: Other human health activities. Its registered office is in Seneffe.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0691.703.238
- Incorporation
- 05/03/2018
- Legal form
- Private limited company
- Registered office
- Tiène à Coulons 3
7181 Seneffe · WallonieSee on map - Contributed capital
- 18 600,00 €
- Latest accounts
- 31/12/2025
Signals
ProfitableSolid equityPositive cashflowPositive EBITDA
Financials
Source · NBB, 8 filingsTrend over 8 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 260,7 k € | -16.8% | 313,3 k € | +0.3% | 312,3 k € | +0.2% | 311,7 k € | +64.4% | 189,6 k € |
| EBITDA | 252,7 k € | -18.9% | 311,7 k € | +0.2% | 311,1 k € | +0.5% | 309,5 k € | +64.3% | 188,4 k € |
| Operating result | 199,2 k € | -24.3% | 263,3 k € | +0.7% | 261,5 k € | +0.4% | 260,5 k € | +82.3% | 142,9 k € |
| Net result | 142,3 k € | -29.1% | 200,7 k € | +3.0% | 194,8 k € | -2.9% | 200,7 k € | +78.2% | 112,6 k € |
| Balance sheet | |||||||||
| Equity | 199,7 k € | -14.8% | 234,4 k € | -41.5% | 400,7 k € | +12.6% | 355,9 k € | +39.5% | 255,2 k € |
| Total assets | 602,8 k € | +46.6% | 411,2 k € | -1.4% | 416,9 k € | -16.3% | 498,1 k € | +24.0% | 401,7 k € |
| Cash | 133,9 k € | +251% | 38,2 k € | -5.3% | 40,3 k € | -83.4% | 243,3 k € | +78.2% | 136,5 k € |
| Debts | 403,1 k € | +128% | 176,8 k € | +990% | 16,2 k € | -88.6% | 142,2 k € | -2.9% | 146,5 k € |
Valuation
Indicative valuation
As an indication, this company is worth
between 1 M€ and 2,5 M€
See the valuationBoard of directors
Source · NBB, accounts to 31/12/20251 active
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Maxime Depoorter | DirectorAdministrator - managerended |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 29/06/2026 | 25/07/2025 | 09/07/2024 | 03/07/2023 | 14/07/2022 | 20/07/2021 |
| General meeting | 26/06/2026 | 27/06/2025 | 06/06/2024 | 30/06/2023 | 24/06/2022 | 25/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 8 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2025 | 26/06/2026 | 29/06/2026 | French | |
| Micro model | 31/12/2024 | 27/06/2025 | 25/07/2025 | French | |
| Micro model | 31/12/2023 | 06/06/2024 | 09/07/2024 | French | |
| Micro model | 31/12/2022 | 30/06/2023 | 03/07/2023 | French | |
| Micro model | 31/12/2021 | 24/06/2022 | 14/07/2022 | French | |
| Micro model | 31/12/2020 | 25/06/2021 | 20/07/2021 | French | |
| Micro model | 31/12/2019 | 26/06/2020 | 18/08/2020 | French | |
| Abridged model | 31/12/2018 | 28/06/2019 | 25/07/2019 | French |
Valuation
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 1 M€ and 2,5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Maxime Depoorter | DirectorAdministrator - managerended |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official GazetteSimilar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsYear
Identity
Incorporation
Name
Registered office
Annual accounts
Filings8 filings
201820192020202120222023202420252026
LABO M.D.LABO MD
Tiène à Coulons 3, 7181 Feluy
CurrentPlanned, not yet servedEndedAccounts filedToday
Registered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Tiène à Coulons 3, 7181 FeluyCurrent | accounts 2021 → 2025 | Accounts 2025 · 2026-00224133 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| LABO M.D.Current | accounts 2025 | Accounts 2025 · 2026-00224133 |
| LABO MD | accounts 2021 → 2024 | Accounts 2024 · 2025-00305884 |
Events
- 2025Annual accounts 2025142,3 k €↓
- 2025Name changeLABO M.D.
- 2024Annual accounts 2024200,7 k €↑
- 2023Annual accounts 2023194,8 k €↓
- 2022Annual accounts 2022200,7 k €↑
- 2021Annual accounts 2021112,6 k €↓
- 2020Annual accounts 2020121 k €↑
- 2019Annual accounts 2019120,8 k €↑
- 2018Annual accounts 2018112,1 k €
- 05/03/2018IncorporationPrivate limited company